300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Mobile
Wellness
Education
Automotive
Hospitality
Biotechnology
Consumer
Sports
Legal
eSports
Construction
Software
Renewable Energy
Crowdfunding
Venture Capital
Theatre
Medical
Fashion
Recruiting
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Web3
Mobile Apps
Climate
Music
Art
Life Science
Real Estate
Sporting Goods
Manufacturing
Wine and Spirits
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Food and Beverage
Publishing
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Non Profit
Enterprise
Internet
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Sudan
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Turkey
Myanmar
Uruguay
Uganda
Moldova
Seychelles
Paraguay
Botswana
Japan
Ireland
Canada
South Africa
United Kingdom
France
Georgia
Ghana
Denmark
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Angola
Bangladesh
Europe
Belgium
Cyprus
Barbados
Jordan
Qatar
Austria
Azerbaijan
Ethiopia
Bulgaria
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Ecuador
Bolivia
Algeria
Finland
Belize
Hungary
Italy
Grenada
Israel
Belarus
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Angel Investors in United Kingdom (August 2026)

The most active angel investors investing in United Kingdom Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
31 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Nadav Rosenberg
Angel
6 United Kingdom, France, Israel Seed, Pre-Seed, Series A Software, Biotechnology, Artificial Intelligence $850k–$21M
Jude Gomila
Angel
4 United States, United Kingdom, India Seed, Pre-Seed, Angel Software, Information Technology, Biotechnology $70k–$5M
Peder Nielsen
Angel
4 United Kingdom Seed, Convertible Note Biotechnology
Charlie Songhurst
Angel
4 United Kingdom, United States, Germany Seed, Pre-Seed Software, Information Technology, Artificial Intelligence $542k–$8.5M
Darrin Disley
Angel
4 United Kingdom Seed, Series A Biotechnology, Health Care, Big Data $458k–$3.7M
Paul Wicks
Angel
3 United Kingdom, United States, Japan Seed, Pre-Seed, Series A Software, Wellness, E-Commerce $539k–$11M
Edward Lando
Angel
3 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Artificial Intelligence, FinTech $125k–$37M
Nadav Ben-Chanoch
Angel
3 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Information Technology, Artificial Intelligence $120k–$30M
Hugh Grant
Angel
3 United Kingdom Seed, Convertible Note Biotechnology
DrPano Kroko Churchill
Angel
3 United Kingdom Angel, Series A Health Care, Therapeutics, Biotechnology $150k–$458k
Bradley Horowitz
Angel
3 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $150k–$120M
Stefano Bernardi
Angel
3 Italy, United Kingdom, France Seed, Pre-Seed Software, Blockchain, Biotechnology $100k–$45M
Milad Alucozai
Angel
3 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $110k–$60M
Ian Hogarth
Angel
3 United Kingdom, United States, Germany Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $698k–$43M
Jeff Dean
Angel
3 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$60M
Chris Mairs
Angel
2 United Kingdom, United States Seed, Pre-Seed, Angel Software, FinTech, Financial Services $334k–$5M
Damien Lane
Angel
2 United Kingdom, United States, Ireland Seed, Pre-Seed, Series A SaaS, Software, Health Care $459k–$16M
Inaki Berenguer
Angel
2 Spain, United States, United Kingdom Seed, Angel, Pre-Seed FinTech, Financial Services, E-Commerce $233k–$9M
Matt Clifford
Angel
2 United Kingdom, United States, India Seed, Pre-Seed, Venture - Series Unknown Software, Artificial Intelligence, FinTech $55k–$34M
Nicholas Edwards
Angel
2 United Kingdom Seed, Venture - Series Unknown Medical, Health Care, Life Science
Simon Galbraith
Angel
2 Croatia, United Kingdom Seed, Pre-Seed, Venture - Series Unknown Software, Health Care, Life Science
Tim Davis
Angel
2 United States, United Kingdom, Germany Series A, Series B, Seed Health Care, Biotechnology, Medical
Paul Forster
Angel
2 United Kingdom, Germany, United States Seed, Series A, Pre-Seed Software, FinTech, Financial Services $1.1M–$18M
Ariel Poler
Angel
2 United States, Spain, Mexico Seed, Series A, Angel Software, Social Media, Internet $455k–$7.9M
Jon Oringer
Angel
2 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Information Technology, FinTech $100k–$31M
Aidan Gomez
Angel
2 United States, United Kingdom, Canada Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $1.8M–$12M
Nicolas Berggruen
Angel
2 United States, United Kingdom, Brazil Seed, Series A, Series B Software, Artificial Intelligence, Machine Learning $850k–$26M
Ersin Pamuksüzer
Angel
2 Turkey, Germany Seed, Series A Education, Life Science, Virtual Reality $300k–$500k
Robert Kopple
Angel
2 United States, United Kingdom Convertible Note, Venture - Series Unknown FinTech, Finance, Life Science $3.3M–$4.8M
Michelle Tempest
Angel
2 United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Cannabis
Ed Parkinson
Angel
2 United Kingdom Seed Health Care, Life Science, Biotechnology $1.9M–$3M
Jim Mellon
Angel
2 United States, United Kingdom, Germany Series A, Seed Biotechnology, Food and Beverage, Health Care
Pratima Aiyagari
Angel
2 United Kingdom, France, Germany Seed, Pre-Seed, Series A SaaS, Analytics, Cyber Security $1M–$12M
Gilad Engel
Angel
2 France, Israel, United Kingdom Seed, Pre-Seed Hardware, Analytics, Biotechnology $1.2M–$1.9M
Mark Evans
Angel
2 United Kingdom, United States, The Netherlands Series A, Seed Retail, Fashion, Software $1.4M–$24M
Jan Hruska
Angel
2 United Kingdom Seed, Venture - Series Unknown Medical, Health Care, Life Science
Tim Dempsey
Angel
2 United Kingdom Seed, Series A Software, SaaS, Financial Services $962k–$13M
Abdulaziz Alrashed
Angel
2 United Kingdom Seed, Pre-Seed Analytics, Biotechnology, Information Technology
Vishal Rao
Angel
2 United States, India, Canada Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$25M
Amar Shah
Angel
2 United Kingdom, Poland, Germany Pre-Seed, Seed, Angel Artificial Intelligence, Software, Health Care $642k–$15M
Mati Staniszewski
Angel
2 United States, United Kingdom, Poland Seed, Pre-Seed, Series A Artificial Intelligence, Software, SaaS $2M–$75M
Patrick Pichette
Angel
2 United Kingdom, Germany, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $943k–$95M
Serge Chiaramonte
Angel
2 United Kingdom, United States, France Seed, Pre-Seed FinTech, Financial Services, Software $637k–$37M
Nick Boyle
Angel
2 United Kingdom Seed Biofuel, Agriculture, Artificial Intelligence $3M–$3M
Ahmed Medhat
Angel
1 United States, United Kingdom Seed, Pre-Seed Artificial Intelligence, Information Technology, Machine Learning
Chris Paul
Angel
1 United States, France, Portugal Seed, Series A Food and Beverage, Sports, Health Care
Marcus East
Angel
1 United Kingdom Seed Software, Health Care, Biotechnology
Sam Fazeli
Angel
1 United Kingdom Post-IPO Equity Education, Health Care, Biotechnology
Johnathan Matlock
Angel
1 United Kingdom Seed, Pre-Seed Biotechnology, Medical, Health Care
Access all 287 angel investors in United Kingdom Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 31 investments in United Kingdom Biotech startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 62
  • Round size: Seed $537k–$25M; Series A $4.1M–$50M; Series B $1.6M–$56M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 6 investments in United Kingdom Biotech startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Lindus — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 4 investments in United Kingdom Biotech startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 64
  • Round size: Seed $1.4M–$5M; Angel $70k–$1.3M; Pre-Seed $660k–$2.9M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Vaire — Conventional chips waste all their energy as heat. Vaire's groundbreaking technology will recover and recycle most of its energy, delivering low energy, high performance compute for the AI era.
  • Clara — Clara is an AI-powered primary care doctor.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Show all investments...

Peder Nielsen
Angel · Copenhagen, Hovedstaden, Denmark · 4 investments in United Kingdom Biotech startups

Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 4 investments in United Kingdom Biotech startups

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 214
  • Round size: Seed $1.1M–$8.5M; Pre-Seed $542k–$5.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Skrap — Skrap is an on-demand mobile marketplace for skip hire and other waste collection services.
  • Uncovr — Surgical video is the biggest dark data in medicine. We turn it into operative reports, billing codes, and clinical intelligence automatically
  • Structured AI — Construction AI QA/QC software that automatically reviews drawing packages and catches errors, code issues, and coordination clashes before they reach the field.
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 4 investments in United Kingdom Biotech startups

Darrin Disley is based out of Cambridge, Cambridgeshire, and is the Executive Chairman and Director of Cardiogeni. Darrin previously worked at Mogrify as Chief Executive Officer, Director, and Investor. Darrin Disley attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 5
  • Round size: Seed $458k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development. The company uses a precision cell programming system to convert stem cells into defined human cell types and supplies a portfolio of reprogrammed cells, custom cell development services, and research-readyhuman cell models for scientific and pharmaceutical use. Bit.bio also supports integration of its products into partner research ecosystems and offers platform capabilities that help identify transcription factors for specific cell states. Its focus includes enabling scalable access to human cell models for experiments, screening workflows, and therapeutic investigation.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Paul Wicks
Angel · London, England, United Kingdom · 3 investments in United Kingdom Biotech startups

Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.

Show more...

Investment focus

  • Industry: Software, Wellness, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 17
  • Round size: Seed $3M–$6.6M; Pre-Seed $539k–$1M; Series A $6.7M–$11M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
  • Epiminds — Epiminds develops multi-agent AI systems to run marketing end-to-end.
  • Scooch — All-in-one subscription to eliminate hassle from your pet healthcare. From online assessment, health tracking and AI assistant to 24/7 vet support and vet-formulated treatments.
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 3 investments in United Kingdom Biotech startups

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 478
  • Round size: Seed $975k–$7M; Pre-Seed $125k–$3.4M; Series A $5.5M–$37M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Humera — Humera - AI CAPTCHA That Knows You're Human
  • Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
  • Heywa Labs — Heywa Labs develops Generative UX (GenUX), an AI-driven interface layer that creates dynamic, adaptive user experiences beyond static text or links. Their flagship app, Heywa, delivers visual, tappable "stories" of cards for tasks like cooking, travel, fitness, and DIY, reconfiguring in real-time based on user interactions.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 3 investments in United Kingdom Biotech startups

Nadav Ben-Chanoch

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 226
  • Round size: Seed $500k–$6M; Pre-Seed $120k–$2.5M; Series A $4M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • micro1 — We help companies hire and manage the best software engineers easily.
  • TRIVER — Triver develops online and digital tools to assist and support various financial services. It is based in London, England.
  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
Show all investments...

Hugh Grant
Angel · Saint Louis, Missouri, United States · 3 investments in United Kingdom Biotech startups

Hugh Grant is the Chief Executive Officer at H.B.Grant and Associates.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
DrPano Kroko Churchill
Angel · Seattle, Washington, United States · 3 investments in United Kingdom Biotech startups

Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com

Show more...

Investment focus

  • Industry: Health Care, Therapeutics, Biotechnology
  • Stage:Angel, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Angel $150k–$458k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amrit Advanced Biotech — Company working in Genetics, Telomeres health applications, cancer mitigation and lengthening of....
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 3 investments in United Kingdom Biotech startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 132
  • Round size: Seed $150k–$18M; Series A $7.2M–$36M; Series B $19M–$120M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
  • Odyssey — Odyssey is an AI lab pioneering general world models: causal, multimodal systems that learn to understand and simulate the world.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in United Kingdom Biotech startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Blockchain, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 17
  • Round size: Seed $100k–$45M; Pre-Seed $874k–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Freatic — Building the monetization layer for your alpha
  • Niulinx — Niulinx specializes in providing autonomous driving technology solutions based on artificial intelligence, connectivity, and data analytics.
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 3 investments in United Kingdom Biotech startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 55
  • Round size: Seed $1M–$7M; Pre-Seed $110k–$5M; Series A $13M–$60M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
  • Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 3 investments in United Kingdom Biotech startups

Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 60
  • Round size: Seed $1.5M–$7.9M; Pre-Seed $698k–$7.5M; Series A $11M–$43M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Cordless — Bridging the gap between voice and text
  • Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 3 investments in United Kingdom Biotech startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 104
  • Round size: Seed $2.5M–$35M; Pre-Seed $450k–$2.3M; Series A $10M–$60M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Moonlake AI — Vibe code games and worlds into existence.
  • Belfort — Enabling Fully Homomorphic Encryption through Hardware Acceleration
  • Periodic Labs — From bits to atoms.
Show all investments...

Chris Mairs
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups

Chris Mairs - Venture Partner @ Entrepreneurs First

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 26
  • Round size: Seed $655k–$5M; Angel $334k–$707k; Pre-Seed $900k–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
  • Briefcase — AI agents that capture invoices, code transactions, handle VAT, reconcile banks, and build working papers in real time. Fully integrated with Xero and QuickBooks. Two-week free trial.
  • Borderless — Borderless is a workforce migration platform.It offers automation solutions that focuses on all aspects of hiring and onboarding of foreign workers, including recruitment, immigration, relocation, and compliance.
Show all investments...

Damien Lane
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Show more...

Investment focus

  • Industry: SaaS, Software, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 38
  • Round size: Seed $459k–$3.1M; Pre-Seed $660k–$1M; Series A $3.2M–$16M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
  • Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
  • Jump — Launched in late 2018 after 2 years of R&D supported by competitive grant funding from the UK & NL Government, Jump is a people analytics platform that gives everyone a chance to succeed. By understanding what makes people unique and linking this to business outcomes, Jump gives more personalised job recommendations to professionals, inturn attracting much better job applications to businesses. Win:win for both!Jump is backed by outstanding investors whose successes include Revolut, CarWow, GoodLord, Magic Pony and many others. Jump collaborates with Imperial College and other top UK Universities in the development of the data science and algorithms behind Jump.Looking for new career options or just a change of scenery? Sign up and receive personalised job matches - absolutely and always for free - at https://app.jump.work/jobsLooking to transform your talent attraction using people analytics? Drop me a note and we can chat!
Show all investments...

Inaki Berenguer
Angel · New York, New York, United States · 2 investments in United Kingdom Biotech startups

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, E-Commerce
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 27
  • Round size: Seed $500k–$9M; Angel $233k–$1M; Pre-Seed $1.2M–$2M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Goin — Goin is a Barcelona-based fintech platform founded in 2017 that provides a unified money optimization ecosystem combining automated savings, investments, digital assets, and rewards. The app enables users to aggregate multiple bank accounts via PSD2, centralizing financial data and automating decisions through its AI engine, gaIA. Goin integratesfinancial automation, portfolio tools, and cash-back incentives in a single interface used primarily by young European consumers. The company operates in a regulated environment, is registered with the Bank of Spain as a crypto service provider, and has expanded across Southern Europe. In 2025, Goin launched KernelPay, its B2B Banking-as-a-Service (BaaS) infrastructure for payments, accounts, and wallet management.
  • Permisso — Bankflip is a mobile application that collects and processes income, tax, employment, and relevant data in real-time.
  • Momento — Momento is an insurtech company with the objective of revolutionizing the insurance industry in Latin America, starting with car insurance. We want to make insurance easy and accessible for the underserved population in LATAM.
Show all investments...

Matt Clifford
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 41
  • Round size: Seed $764k–$7M; Pre-Seed $55k–$4.2M; Venture - Series Unknown $2.4M–$34M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Stackfix — Stackfix operates as a software comparison platform.
  • Rivan Industries — Rivan Industries designs and builds modular, vertically integrated, synthetic fuel plants.
  • Asymmetric Security — Asymmetric Security is an AI-native cybersecurity startup specializing in digital forensics and incident response. It combines elite forensic experts with proprietary AI to accelerate investigations, especially Business Email Compromise (BEC) attacks, at less than half the cost of competitors while shrinking timelines from days to hours.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nicholas Edwards
Angel · Oxford, Oxfordshire, United Kingdom · 2 investments in United Kingdom Biotech startups

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Simon Galbraith
Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in United Kingdom Biotech startups

Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Croatia, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
  • Syskit — Syskit Point keeps your Microsoft 365 environment under control - secured, cost-optimized, and AI confident.
Show all investments...

Tim Davis
Angel · Santa Monica, California, United States · 2 investments in United Kingdom Biotech startups

Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries. He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 10
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bryn Pharma — Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
  • Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
  • MycoMedica Life Sciences, PBC — Psychedelic Medicines
Show all investments...

Paul Forster
Angel · Cambridge, Massachusetts, United States · 2 investments in United Kingdom Biotech startups

Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 81
  • Round size: Seed $1.1M–$7.2M; Pre-Seed $1.1M–$3.5M; Series A $3.9M–$18M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Oraion — Your single source of truth for enterprise data
  • Capsa AI — Providing next-generation investors with a competitive edge.
  • Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
Show all investments...

Ariel Poler
Angel · San Francisco, California, United States · 2 investments in United Kingdom Biotech startups

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

Show more...

Investment focus

  • Industry: Software, Social Media, Internet
  • Stage:Seed, Series A, Angel
  • Geography: United States, Spain, Mexico

Investor stats

  • Total investments: 45
  • Round size: Seed $455k–$7M; Angel $1M–$1.7M; Series A $3M–$7.9M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Goin — Goin is a Barcelona-based fintech platform founded in 2017 that provides a unified money optimization ecosystem combining automated savings, investments, digital assets, and rewards. The app enables users to aggregate multiple bank accounts via PSD2, centralizing financial data and automating decisions through its AI engine, gaIA. Goin integratesfinancial automation, portfolio tools, and cash-back incentives in a single interface used primarily by young European consumers. The company operates in a regulated environment, is registered with the Bank of Spain as a crypto service provider, and has expanded across Southern Europe. In 2025, Goin launched KernelPay, its B2B Banking-as-a-Service (BaaS) infrastructure for payments, accounts, and wallet management.
  • Reloadly — Send gift cards, airtime & payouts globally with one API. Scalable, instant, developer-friendly platform for rewards and incentives.
  • Openlytics — Openlytics is a Visual Data Platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape the direction ofthe product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
Show all investments...

Jon Oringer
Angel · Miami, Florida, United States · 2 investments in United Kingdom Biotech startups

Jon Oringer is the founder and chairman of Shutterstock.

Show more...

Investment focus

  • Industry: Software, Information Technology, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 133
  • Round size: Seed $1.1M–$5.5M; Pre-Seed $100k–$3.4M; Series A $4M–$31M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
  • Unsloth AI — Unsloth is an open-source, no-code web UI for training, running and exporting open models in one unified local interface.
  • OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.
Show all investments...

Aidan Gomez
Angel · Oxford, Arkansas, United States · 2 investments in United Kingdom Biotech startups

Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 17
  • Round size: Seed $2.8M–$12M; Pre-Seed $1.8M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • DatologyAI — DatologyAI optimize training efficiency, maximize performance and reduce compute costs with expert curation.
  • Extropic AI — The next era of computing isn't dead. It's alive. More coming soon.
  • Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Show all investments...

Nicolas Berggruen
Angel · Los Angeles, California, United States · 2 investments in United Kingdom Biotech startups

Nicolas Berggruen is the Founder and Chairman of the Berggruen Institute. He attended New York University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Brazil

Investor stats

  • Total investments: 34
  • Round size: Seed $850k–$4.5M; Series A $7M–$25M; Series B $25M–$26M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Helm.ai — Explore Helm.ai's AI software for high-end ADAS through Level 4 autonomous vehicles. Helm.ai offers a full suite of full-stack AI software, foundation models, and generative AI development and validation tools for production-bound projects.
  • The Data Foundation — Story is AI-native infrastructure for the intellectual property economy.
  • iLoF — iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development
Show all investments...

Ersin Pamuksüzer
Angel · Bodrum, Mugla, Turkey · 2 investments in United Kingdom Biotech startups

Ersin Pamuksüzer

Show more...

Investment focus

  • Industry: Education, Life Science, Virtual Reality
  • Stage:Seed, Series A
  • Geography: Turkey, Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $300k–$500k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aposto — All-in-one media service currently based in Istanbul, Turkey.
  • VRLab Academy — VRLab Academy | Virtual Experiments
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States · 2 investments in United Kingdom Biotech startups

Robert C. Kopple is based out of Vancouver, Ontario, and is the Partner of Kopple, Klinger & Elbaz. Robert previously worked at Gelum Resources as a Board of Directors. Robert C. Kopple attended New York University.

Show more...

Investment focus

  • Industry: FinTech, Finance, Life Science
  • Stage:Convertible Note, Venture - Series Unknown
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $3.3M–$4.8M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Michelle Tempest
Angel · 2 investments in United Kingdom Biotech startups

Michelle Tempest

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Cannabis
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Daye — Daye is setting a new standard in period care and gynae health. We offer period products, vaginal microbiome screenings, and a period pain clinic.
  • Sanome — Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people.
  • Medwise.ai — Medwise.ai is the Google for doctors.
Show all investments...

Ed Parkinson
Angel · 2 investments in United Kingdom Biotech startups

Ed Parkinson

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $1.9M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Jim Mellon
Angel · 2 investments in United Kingdom Biotech startups

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Health Care
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 29
  • Lead/follow: no public data

Portfolio highlights

  • Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Show all investments...

Pratima Aiyagari
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups

Pratima is a Venture Partner at Nauta Capital and is based in London. At Nauta, Pratima focuses on enterprise software and deep tech domains.Pratima has 18+ years of professional experience. She is a software developer by background and spent several years in Silicon Valley working on developing intelligent network services in the networkmanagement domain. Pratima joins Nauta from US-based cybersecurity-focused investment firm Paladin Capital. Previously, Pratima led investments and acquisitions at Cisco Corporate Development in Europe with a specific focus on ML/AI, Enterprise Collaboration and Silicon. During her investment career, Pratima led an investment or held board seats in Aimotive, Adbrain, Evrythng, Secure Code Warrior, decentriq, Dashbird, and several fund investments. She also managed investments in several companies including Behaviosec, Italtel, ip.access, and Corvil.Pratima received her MBA from INSEAD in France and an MS in computer science from the Virginia Polytechnic Institute and State University in the US. Pratima is a co-author of a US patent in the area of network device clusters and high availability.

Show more...

Investment focus

  • Industry: SaaS, Analytics, Cyber Security
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Germany

Investor stats

  • Total investments: 11
  • Round size: Seed $1.2M–$8.3M; Pre-Seed $1M–$1.2M; Series A $7M–$12M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • Mindflow — Mindflow is a No-Code & Agentic Automation & Orchestration Platform that enables all Enterprise Cyber IT Professionals to Automate Mundane tasks and to deploy AI Agents at scale.
  • ESPROFILER — ESPROFILER uniquely combines security spend, commercials, and capabilities with threats helping security leaders maximise their investments.
Show all investments...

Gilad Engel
Angel · 2 investments in United Kingdom Biotech startups

Gilad Engel

Show more...

Investment focus

  • Industry: Hardware, Analytics, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: France, Israel, United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Seed $1.2M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Joe — Joe is an financial service that reimburses and allows ALL expenses to be paid in several installments.
  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • Fourier Optics — Fourier optics creates meta-surface based optical systems for Augmented Reality glasses
Show all investments...

Mark Evans
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups

Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.

Show more...

Investment focus

  • Industry: Retail, Fashion, Software
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 36
  • Round size: Seed $1.4M–$8M; Series A $3.2M–$24M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
  • Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Show all investments...

Jan Hruska
Angel · Abingdon, Oxfordshire, United Kingdom · 2 investments in United Kingdom Biotech startups

Jan Hruska

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Tim Dempsey
Angel · 2 investments in United Kingdom Biotech startups

Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.

Show more...

Investment focus

  • Industry: Software, SaaS, Financial Services
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 18
  • Round size: Seed $962k–$2.7M; Series A $6.4M–$13M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
  • PPC Protect — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
  • AeroCloud — Reinvent airport management with cloud-based software that enhances efficiency, unifies operations, and helps airports deliver a seamless, people-first experience.
Show all investments...

Abdulaziz Alrashed
Angel · 2 investments in United Kingdom Biotech startups

Abdulaziz Alrashed.

Show more...

Investment focus

  • Industry: Analytics, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
Show all investments...

Vishal Rao
Angel · Boston, Massachusetts, United States · 2 investments in United Kingdom Biotech startups

Advisory CTO and Angel Investor

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 84
  • Round size: Seed $500k–$8.8M; Pre-Seed $500k–$2.1M; Series A $3.8M–$25M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Aquaria — Aquaria provides solutions to secure access to clean water. The organization adapts its approaches based on the needs of these communities. It addresses water-related challenges through various methods.
  • Delphi — Delphi turns your expertise into an always-on presence, so you can grow your reach, serve your audience, and lead with clarity, without burning out.
  • Cambridge Terahertz — Cambridge Terahertz, a leader in terahertz (THz) imaging technology, offers an AI-powered Concealed Weapons Detection (CWD) solution to enhance workplace security. Our patent-pending system can see through clothing, luggage, plastic, paper, ceramics, and cardboard to detect concealed threats, including firearms, knives, and explosives.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Amar Shah
Angel · San Diego, California, United States · 2 investments in United Kingdom Biotech startups

Amar Shah is based out of London and is the Founder & Partner of Dhyan VC. Amar previously worked at Firstminute Capital as an Entrepreneur In Residence. Amar Shah attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United Kingdom, Poland, Germany

Investor stats

  • Total investments: 10
  • Round size: Seed $4.8M–$15M; Pre-Seed $642k–$2.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Emm — Emm is developing the next generation of consumer health tools to manage your health on your terms. We want to empower everyone to change the quality of their life by inherently understanding their health though technology and specialist knowledge.
  • Tolemy Bio — The AI-native virtual cell platform for therapeutic development and manufacture.
  • ReSpo.Vision — Enhance your sports analytics and visualise the game using AI & Computer Vision-powered Sports Tracking and Event Data.
Show all investments...

Mati Staniszewski
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups, 15 in the past 12 months

Mati Staniszewski is the Co-Founder of ElevenLabs.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Poland

Investor stats

  • Total investments: 22
  • Round size: Seed $4.5M–$11M; Pre-Seed $2M–$20M; Series A $16M–$75M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • imagi — Programming has never been this much fun! Learn to create with code, share your designs with friends on the imagiLabs app and customize your imagiCharm - a fun, easy-to-use, colorful, and educational toy for girls. Imagine it. Code it. Wear it.
  • Dwelly — Dwelly acquires and partners with independent UK lettings agencies, helping owners exit smoothly, profitably and on their terms. Get a free agency valuation.
  • Arrakis Security — Secure the enterprise agents where they're deployed. Total visibility, governance, and remediation for the autonomous workforce.
Show all investments...

Patrick Pichette
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups

Patrick Pichette is based out of London, England, and is the Partner of Inovia Capital and also Board Member of Cohere. Patrick Pichette previously worked at Twitter as a Board of Directors. Patrick Pichette attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 27
  • Round size: Seed $943k–$10M; Series A $10M–$95M; Series B $15M–$95M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Mobai — Provider of attack detection, image manipulation detection and authentication. Strong and successful research team on biometrics.
  • Kaedim — AI-powered 3D asset creation service delivering fast, production-ready 3D assets. Scale 3D pipelines without hiring, accelerate 3D game art production, and reduce 3D asset costs by up to 90%.
  • Clove — Building the financial institution of the future, to make money make sense.
Show all investments...

Serge Chiaramonte
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups

Serge Chiaramonte

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Software
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 63
  • Round size: Seed $1.2M–$5.3M; Pre-Seed $637k–$37M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Desia — Desia provides advanced AI applications for productivity, automation, and analytics for financial services.
  • StackOne — Accelerate your SaaS growth with our unified API solution for HRIS, ATS, and CRM. Say "yes" to customers, build advanced integrations quickly, and experienced the best data privacy controls in the market.
  • Tranched — Introducing real-time on-chain securitisation. Fintech Lenders and Professional Investors can now launch an institutional-grade transaction up to 90% faster than before.
Show all investments...

Nick Boyle
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotech startups

In 2010, Nick founded Lightsource Renewable Energy, then just a six-person start-up, which quickly grew over 5 years to become Europe’s largest solar developer and operator and a recognised global leader. In his role as Group CEO, Nick’s dynamic leadership and vision has driven the company to tremendous success and in December 2017, Lightsourceannounced a strategic partnership with BP which has committed aggressively to accelerate the low carbon transition. The company has rebranded to Lightsource BP in affirmation of this powerhouse commitment which is set to shape the future of global energy delivery. Nick previously sat at Board and Senior Director level in a number of leading retail financial service companies. Throughout his career, Nick has always been recognised for his entrepreneurial skill and success in pairing retail financial products with low-risk, predictable investments.

Show more...

Investment focus

  • Industry: Biofuel, Agriculture, Artificial Intelligence
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $3M–$3M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Better Origin — At Better Origin, our mission is to fix the broken food chain by converting waste into high-value insect products.
  • Better Origin — At Better Origin, our mission is to fix the broken food chain by converting waste into high-value insect products.
Show all investments...

Ahmed Medhat
Angel · San Francisco, California, United States · 1 investments in United Kingdom Biotech startups

Ahmed Medhat - Research Scientist, Core Data Science @ Meta

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Machine Learning
  • Stage:Seed, Pre-Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 8
  • Lead/follow: no public data

Portfolio highlights

  • Ntropy Network — Unlock the power of transactions. Our technology enables flexible and autonomous banking data cleansing, labeling and enhancement.
  • Grin Gaming — GrinData micro markets software leverages best-in-class high-frequency trading and machine learning to deliver reliable odds pricing on the most markets.
  • Anarchy — Anarchy builds a cloud platform for AI pioneers to build LLM tools augmented with external interactivity.
Show all investments...

Chris Paul
Angel · San Francisco, California, United States · 1 investments in United Kingdom Biotech startups

Christopher Emmanuel Paul is an American professional basketball player for the Oklahoma City Thunder of the National Basketball Association.

Show more...

Investment focus

  • Industry: Food and Beverage, Sports, Health Care
  • Stage:Seed, Series A
  • Geography: United States, France, Portugal

Investor stats

  • Total investments: 19
  • Lead/follow: no public data

Portfolio highlights

  • Scout - Make Money Moves — Scout is the financial wellness platform for student athletes in the new NIL era. We empower athletes to make better financial decisions with live financial education sessions and personalized, tech-enabled service.
  • Buoy — Zero sugar liquid electrolytes and ionic trace minerals that blend with any beverage, even alcohol and coffee. No sugar, no stevia, no dextrose, no flavorings and no artificial ingredients. Gluten and major allergen free. Vegan and non-GMO.
  • Umaro Foods — Umaro Foods specializes in developing a plant-based protein source from ocean-farmed seaweed.
Show all investments...

Marcus East
Angel · Greater Seattle Area, Washington, United States · 1 investments in United Kingdom Biotech startups

Marcus East is an international technology and product executive and CDO/CIO/CTO with over 25 years experience of working in the Information Technology, specializing in, Digital Product, Digital Transformations and Electronic Commerce. He has two degrees: a Bachelor’s with honors in Management & Information Technology (Modular) fromLondon Guildhall and a Master’s in Management from the University of Cambridge. He is also a full member of the Chartered Management Institute, a Fellow of the British Computer Society Chartered Institute for IT, and holds the IoD Certificate in Company Direction. Marcus started his career with IBM where he spent six years honing his consulting and strategy skills, before joining Omnicom’s agency.com where he spent two years learning about the importance of user experience, and further developed his management skills. Since then, he has held senior digital leadership positions for a number of major brands, including Comic Relief, Apple and National Geographic.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • OxCan — Enabling curative cancer treatment through early detection
Show all investments...

Sam Fazeli
Angel · London, England, United Kingdom · 1 investments in United Kingdom Biotech startups

Sam Fazeli is the Non Executive Director at Arecor Limited.

Show more...

Investment focus

  • Industry: Education, Health Care, Biotechnology
  • Stage:Post-IPO Equity
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Arecor — Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.In addition toits internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Show all investments...

Johnathan Matlock
Angel · Bedford, Bedfordshire, United Kingdom · 1 investments in United Kingdom Biotech startups

Johnathan Matlock is Co-Founder Science Angel Syndicate.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • MintNeuro — MintNeuro is pioneering the use of semiconductor technology in next-generation neural implants.
  • Argonaute RNA — Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.
  • Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Show all investments...

Biotech Angel investor funding in United Kingdom at a glance

Stats across 231 deals from 287 investors.

287
investors
in United Kingdom Biotech startups
231
deals
in United Kingdom Biotech startups
$3.5M
median round
in United Kingdom Biotech startups
7%
lead investors
lead at least one round
41%
Seed
most common funding stage

Access all 287 angel investors in United Kingdom Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 287 angel investors investing in United Kingdom Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists